82 related articles for article (PubMed ID: 20921905)
1. Mixed variant multicentric Castleman disease treated with rituximab: case report.
Mian H; Leber B
J Pediatr Hematol Oncol; 2010 Nov; 32(8):622. PubMed ID: 20921905
[No Abstract] [Full Text] [Related]
2. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease.
Casquero A; Barroso A; Fernández Guerrero ML; Górgolas M
Ann Hematol; 2006 Mar; 85(3):185-7. PubMed ID: 16341862
[TBL] [Abstract][Full Text] [Related]
3. IL-1RA agonist (anakinra) in the treatment of multifocal castleman disease: case report.
Galeotti C; Tran TA; Franchi-Abella S; Fabre M; Pariente D; Koné-Paut I
J Pediatr Hematol Oncol; 2008 Dec; 30(12):920-4. PubMed ID: 19131781
[TBL] [Abstract][Full Text] [Related]
4. What Is the best treatment for HIV-associated multicentric Castleman disease?
Bower M; Dalla Pria A
Clin Adv Hematol Oncol; 2012 Mar; 10(3):207-9. PubMed ID: 22402432
[No Abstract] [Full Text] [Related]
5. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena.
Ocio EM; Sanchez-Guijo FM; Diez-Campelo M; Castilla C; Blanco OJ; Caballero D; San Miguel JF
Am J Hematol; 2005 Apr; 78(4):302-5. PubMed ID: 15795923
[TBL] [Abstract][Full Text] [Related]
7. Complete remission in 4 patients with human herpesvirus 8-associated multicentric Castleman disease using rituximab and liposomal doxorubicin, a novel chemotherapy combination.
Peker D; Martinez AE; Schwartz MA; Cusnir M
Clin Adv Hematol Oncol; 2012 Mar; 10(3):204-6. PubMed ID: 22402431
[No Abstract] [Full Text] [Related]
8. Multicentric Castleman's disease & HIV infection.
Cotter A; Lambert J; O'Gorman P
Ir Med J; 2009 Oct; 102(9):294-5. PubMed ID: 19902650
[TBL] [Abstract][Full Text] [Related]
9. Complete regression of HIV-associated multicentric Castleman disease treated with rituximab and thalidomide.
Stary G; Kohrgruber N; Herneth AM; Gaiger A; Stingl G; Rieger A
AIDS; 2008 Jun; 22(10):1232-4. PubMed ID: 18525273
[No Abstract] [Full Text] [Related]
10. A case of multicentric Castleman's disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody.
Gholam D; Vantelon JM; Al-Jijakli A; Bourhis JH
Ann Hematol; 2003 Dec; 82(12):766-8. PubMed ID: 12898190
[TBL] [Abstract][Full Text] [Related]
11. Rituximab and thalidomide combination therapy for Castleman disease.
Ramasamy K; Gandhi S; Tenant-Flowers M; Ceesay M; Corderoy S; Marcus R; Schey S
Br J Haematol; 2012 Aug; 158(3):421-3. PubMed ID: 22583139
[No Abstract] [Full Text] [Related]
12. Plasmablastic microlymphoma arising in human herpesvirus-8-associated multicentric Castleman disease in a human immunodeficiency virus-seronegative patient with clinical response to anti-interleukin-6 therapy.
Koenig G; Stevens TM; Peker D
Histopathology; 2015 Dec; 67(6):930-2. PubMed ID: 25900626
[No Abstract] [Full Text] [Related]
13. Multicentric Castleman disease: report of rare disease in Kuwait.
Mohammad BA; Al-Brahim N; Kunjhibava S; Ahmad M; Ahmad M
Gulf J Oncolog; 2009 Jul; (6):48-50. PubMed ID: 20194090
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).
Sobas MA; Alonso Vence N; Diaz Arias J; Bendaña Lopez A; Fraga Rodriguez M; Bello Lopez JL
Ann Hematol; 2010 Feb; 89(2):217-9. PubMed ID: 19636554
[No Abstract] [Full Text] [Related]
15. Vinblastine, rituximab and HAART, treatment of an HIV -positive patient with multicentric Castleman's disease.
van Aalderen MC; Brinkman K; van den Berk GE; Terpstra WE
Neth J Med; 2010 Feb; 68(2):87-90. PubMed ID: 20167961
[TBL] [Abstract][Full Text] [Related]
16. Castleman disease infiltrating great vessels and right atrium.
Garcipérez de Vargas FJ; Vega J; Fernández H; Mogollón MV; Porro R; Gómez-Barrado JJ
Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):669-70. PubMed ID: 22137469
[No Abstract] [Full Text] [Related]
17. Autoimmune pancreatitis in the setting of Castleman disease.
Maithel SK; Pratt W; Kelleher T; Avigan D; Goldman H; Pfeifer W; Pihan GA; Vollmer CM
Pancreas; 2007 Nov; 35(4):384-7. PubMed ID: 18090252
[No Abstract] [Full Text] [Related]
18. Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomide.
Starkey CR; Joste NE; Lee FC
Am J Hematol; 2006 Apr; 81(4):303-4. PubMed ID: 16550518
[No Abstract] [Full Text] [Related]
19. Multicentric Castleman disease complicated by tumor lysis syndrome after systemic chemotherapy.
Lee JH; Kwon KA; Lee S; Oh SY; Kwon HC; Han JY; Hong SH; Kim SH
Leuk Res; 2010 Jan; 34(1):e42-5. PubMed ID: 19747731
[No Abstract] [Full Text] [Related]
20. Castleman disease.
Dham A; Peterson BA
Curr Opin Hematol; 2007 Jul; 14(4):354-9. PubMed ID: 17534161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
